Icon
+91 94997 68112
Login Register

OSENI - (12.5mg;15/30/45mg,25mg;15/30/45mg, Tablet)

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE Takeda
12.5mg;15/30/45mg,25mg;15/30/45mg, Tablet
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and pioglitazone is appropriate
Yes
******* ** **** ** ****** ** ****** *** ****** **** **** ******** ******®, ******®, *** *****® **** *** ********** ******* *** ********** ******** ** *********** ** ********* ************* *** ************ ************* ************. *** ***** ******* *** ********* **** ** ************* *** ******* (*** **, ****), ******* (*** *, ****), ******* (*** **, ****)- ** ******* *** *********. *** ** ****** **** ****** ** ***. ****. *****, ***** ***** ** ***** ** ********* *** ******* ******* **** ******* ********* ****** ******* (**** **, ****). *********, *** **** ** ******** *** *** ** ******* **** *** **** ** *** ********** ** *.*. ****** **. ******* (*.* ***** **** ****)
OSENI Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
******* ******* ******* ******* ******* **** ** ** *** ** ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** *, **** **** ** ** *** ** **** ***** **** ****
  1. *** **, **** : ******* ******** ****** ********* *** **** ** ******* ******* (*** **, ****), ******* (*** *, ****), ******* (*** **, ****)- ** *******
  2. *** *, **** : ****** **** ******* ** ** ** **.
  3. *** *, **** : ***** ***** ** ***** ** ********* *** ******* ******* **** ****** '*** *** ***** *** ******* ********* ****** ******* (**** **, ****).
  4. *** **, **** : *** ** **** ***** ********* ** *** ***** ******* *** ****** ******* ***** ********** ** ****** ******* (**** **, ****)
  5. *** *, **** : ******* ******** ** **
  6. *** **, **** : ******* **** ** ** ** *** ** ******** *** **'* *********.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.